skip navigation

Skip Nav

HIV/AIDS Clinical Trials

Clinical Trial Search Results

181 studies were found about Infecciones simultáneas, Tuberculosis

Evaluation Of The Performance Of The Nitrate Reductase And Resazurin Titre Assay For The Detection of Mycobacterium Tuberculosis Complex From Sputum In A High Tb and Hiv Setting

Condition: Tuberculosis; HIV; AIDS; HIV Infections

NCT ID: NCT01053598

Impact of HIV Infection on Latent Tuberculosis (TB) Among Patients With HIV-TB Co-infection

Condition: Latent Tuberculosis Infection; HIV Infections; Tuberculosis

NCT ID: NCT00692809

Diagnosis and Treatment of Co-infection With Human Immunodeficiency Virus /Latent Tuberculosis Infection (HIV/TBL)

Condition: Human Immunodeficiency Virus (HIV); Tuberculosis (TB); Latent Tuberculosis Infection (LTI)

NCT ID: NCT01875952

Preventive Treatment Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00000638

A Study of MVA85A, in Asymptomatic Volunteers Infected With TB, HIV or Both

Condition: HIV Infections; TB

NCT ID: NCT00480558

Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00000636

Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Suspected Latent Tuberculous Infection

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00000959

Pharmacokinetics (PK) and Safety of 2 Different Doses of Lopinavir/Ritonavir in in HIV/Tuberculosis (TB) Co-infected Patients Receiving Rifampicin Containing Anti-tuberculosis Therapy

Condition: HIV Infections; Tuberculosis

NCT ID: NCT01138202

Isoniazid Plus Antiretroviral Therapy to Prevent Tuberculosis in HIV-infected Persons

Condition: Tuberculosis; Latent Tuberculosis Infection; HIV Infections

NCT ID: NCT00463086

A Study to Compare Three Existing Starting Points of Anti-Retroviral Therapy (ART) Initiation in HIV/Tuberculosis (TB) Co-infected Patients

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00398996

Evaluation of 2 Interferon γ Assays in the Diagnosis of Latent Tuberculosis in HIV-infected Patients.ANRS EP 40 QUANTI SPOT

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00647205

TB (Tuberculosis) Preventive Therapy for HIV Patients With Access to HAART (Highly Active Antiretroviral Therapy)

Condition: Tuberculosis; HIV Infections

NCT ID: NCT00107887

A RCT of Prednisone as Adjunctive Therapy for Hospitalized Patients With Pulmonary TB and HIV Co-infection

Condition: Tuberculosis; HIV Infections

NCT ID: NCT00414414

Observational Study of Specificity of Mycobacterium Tuberculosis Screening and Diagnostics in HIV-Infected Individuals

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00865826

The Pharmacokinetics and Safety of IDV/r With NRTIs in HIV/TB Co-infected Patients Receiving Rifampicin

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00411996

Efavirenz (EFV) in HIV-Infected and HIV/Tuberculosis (TB) Coinfected Children

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00802802

Protective Efficacy Against Tuberculosis (TB) Disease, Safety, and Immunogenicity of MVA85A/AERAS-485 in HIV-Infected Adults (C-030-485)

Condition: Tuberculosis; HIV Infections

NCT ID: NCT01151189

The Safety and Immunogenicity of a TB Vaccine; MVA85A, in Healthy Volunteers Who Are Infected With HIV

Condition: Tuberculosis; HIV Infections

NCT ID: NCT00395720

Efficacy of Tenofovir-Emtricitabine and Efavirenz in HIV Infected Patients With Tuberculosis (ANRS129)

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00115609

The Treatment of Tuberculosis in HIV-Infected Patients

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00001033

Evaluation of Three Regimens of Chemoprophylaxis for Tuberculosis in Patients co-Infected by HIV and Mycobacterium Tuberculosis

Condition: HIV Infections

NCT ID: NCT00402454

Rifampin-Based Tuberculosis Treatment Versus Rifabutin-Based Tuberculosis Treatment in HIV

Condition: HIV Infection; Tuberculosis

NCT ID: NCT01601626

Comparing Daily vs Intermittent Regimen of ATT in HIV With Pulmonary Tuberculosis

Condition: HIV Infection; Pulmonary TB

NCT ID: NCT00933790

Diagnosis of Tuberculosis Infection in HIV Co-infected Children

Condition: Latent Tuberculosis Infection; Tuberculosis; HIV Infections

NCT ID: NCT00541294

Optimal Time to Initiate Antiretroviral Therapy in HIV & TB Coinfected Adults Being Treated for Tuberculosis

Condition: Acquired Immunodeficiency Syndrome; Tuberculosis

NCT ID: NCT01315301

Tuberculosis and Human Immunodeficiency Virus (HIV) Immune Reconstitution Syndrome Trial (THIRST)

Condition: HIV; Tuberculosis

NCT ID: NCT00851630

Tuberculosis in a Multiethnic Inner City Population

Condition: Acquired Immunodeficiency Syndrome; HIV Infections; Lung Diseases; Tuberculosis; Mycobacterium Tuberculosis

NCT ID: NCT00005379

Efficacy of Thrice Weekly Directly Observed Treatment, Short-course (DOTS) in HIV-associated Tuberculosis

Condition: HIV Infections; Acquired Immunodeficiency Syndrome; Tuberculosis

NCT ID: NCT00698334

Study of Limited Versus Continuous Isoniazid Tuberculosis Preventive Therapy in HIV-infected Persons in Botswana

Condition: Tuberculosis; HIV Infections

NCT ID: NCT00164281

Medical and Economical Impact of IGRAs Diagnosis of Latent Tuberculosis in HIV-infected Patients

Condition: HIV; Tuberculosis; Latent Tuberculosis Infection

NCT ID: NCT00805272

Immediate Versus Deferred Start of Anti-HIV Therapy in HIV-Infected Adults Being Treated for Tuberculosis

Condition: HIV Infection; Tuberculosis

NCT ID: NCT00108862

TBTC Study 23A: Pharmacokinetics of Intermittent Isoniazid and Rifabutin in HIV-TB

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00023348

TBTC Study 23B:Intensive PK of the Nelfinavir Rifabutin Interaction in Patients With HIV-TB

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00023400

Appropriate Timing of HAART in Co-infected HIV/TB Patients

Condition: HIV Infections; Tuberculosis

NCT ID: NCT01014481

Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in Vietnam

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00651066

Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in South Africa

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00640887

Pharmacokinetics of Anti-TB Drugs in HIV/TB Co-infected Children in Ghana

Condition: Tuberculosis; HIV

NCT ID: NCT01687504

Effectiveness of Directly Observed Therapy in Combined HIV and Tuberculosis Treatment in Resource-limited Settings

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00091936

Effectiveness of Anti-HIV Therapy (HAART) in HIV-Infected Patients With Tuberculosis

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00004736

Pharmacokinetics of Emtricitabine/Tenofovir/Efavirenz in HIV-infected Patients With Tuberculosis

Condition: Tuberculosis; HIV Infections

NCT ID: NCT00474435

TBTC Study 23: Treatment of HIV-Related Tuberculosis Using a Rifabutin-Based Regimen

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00023361

Daily Isoniazid to Prevent Tuberculosis in Infants Born to Mothers With HIV

Condition: HIV Infection; Tuberculosis; Pneumocystis Jiroveci Pneumonia

NCT ID: NCT00080119

Is Tuberculin Skin Testing Effective in Screening for Latent Tuberculosis in Patients With HIV?

Condition: Latent Tuberculosis; HIV Infections

NCT ID: NCT00763295

Tuberculosis in HIV Infected Patients in Uganda

Condition: Tuberculosis; HIV Infections

NCT ID: NCT00057421

Metabolism of Antituberculosis Drugs in HIV-Infected Persons With Tuberculosis

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00000950

A Randomized Trial of Three Regimens to Prevent Tuberculosis in HIV-Infected Patients With Anergy

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00402610

Efficacy and Safety of 2 Raltegravir Doses in Naive HIV-1-infected Patients Receiving Rifampin for Active Tuberculosis

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00822315

Immunosuppression in HIV-infected Patients With Tuberculosis in Ethiopia

Condition: HIV Infection; Tuberculosis; Immunosuppression

NCT ID: NCT01252537

Early vs Late Introduction of Antiretroviral Therapy in HIV-infected Patients With Tuberculosis (ANRS 1295 CAMELIA)

Condition: HIV Infection; Tuberculosis

NCT ID: NCT00226434

Interferon-Gamma Release Assays in Tuberculosis (TB) - HIV Co-infected Children

Condition: Tuberculosis; HIV

NCT ID: NCT00604617

Raltegravir + Lamivudine/Abacavir in HIV/Tuberculosis Co-Infected Patients

Condition: HIV Infections; Tuberculosis

NCT ID: NCT01059422

A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00000796

Anti-HIV Drugs for Ugandan Patients With HIV and Tuberculosis

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00078247

Evaluating the Safety and Effectiveness of Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection

Condition: Tuberculosis; HIV Infections

NCT ID: NCT01404312

Screening for Tuberculosis in HIV-infected Patients Eligible for Antiretroviral Treatment

Condition: HIV Infection; Tuberculosis

NCT ID: NCT01433796

Tuberculosis Prevention for HIV Infected Adults

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00057122

Comparison of Nevirapine and Efavirenz for the Treatment of HIV-TB Co-infected Patients (ANRS 12146 CARINEMO)

Condition: Tuberculosis; Aids; Hiv Infections

NCT ID: NCT00495326

Evaluating the Safety, Tolerance, Drug Interactions, and Effective Dosing of a Raltegravir-Containing Antiretroviral Therapy (ART) Regimen in ART-Naive Children Infected With HIV and TB

Condition: HIV Infections; Tuberculosis

NCT ID: NCT01751568

Improving Diagnosis of Tuberculosis in HIV Infected Children in Asia (Cambodia, Vietnam)and Africa (Burkina Faso, Cameroon)

Condition: HIV; Tuberculosis; Pediatric

NCT ID: NCT01331811

Diagnosing Tuberculosis in HIV Infected Children in Peru

Condition: Tuberculosis; Tuberculosis, Pulmonary; HIV Infections

NCT ID: NCT00054769

Gene Expression in HIV and Tuberculosis Co-infection

Condition: Tuberculosis; HIV; IRIS

NCT ID: NCT01611402

Investigational Vaccine for the Prevention of Disseminated Tuberculosis in HIV Infected People

Condition: Tuberculosis; HIV Infections

NCT ID: NCT00052195

Prevention of Early Mortality by Presumptive Tuberculosis (TB) Treatment

Condition: HIV Infection; Tuberculosis

NCT ID: NCT01417988

Quantiferon Gold Test for Detecting Tuberculosis (TB) Infection in HIV/AIDS Patients in South Africa

Condition: Latent Tuberculosis; HIV

NCT ID: NCT02119130

Short Course Intermittent Regimens for the Treatment of HIV-Associated Tuberculosis

Condition: Tuberculosis; Human Immunodeficiency Virus Infections

NCT ID: NCT00376012

Evaluating the Safety of Immediate Versus Deferred Isoniazid Preventive Therapy Among HIV-Infected Pregnant Women

Condition: HIV Infections; Tuberculosis

NCT ID: NCT01494038

Immediate Versus Deferred Antiretroviral Therapy for HIV-Associated Tuberculous Meningitis

Condition: HIV Infections; Tuberculous Meningitis

NCT ID: NCT00433719

Effects of a Protein Calorie Supplement in HIV-infected Women With Tuberculosis

Condition: HIV; Tuberculosis

NCT ID: NCT01635153

Intensive Pharmacokinetics of the Nelfinavir-Rifabutin Interaction in Patients With HIV-Related Tuberculosis Treated With a Rifabutin-Based Regimen

Condition: Tuberculosis; HIV Infections

NCT ID: NCT00018083

Effect of HIV and/or Active Tuberculosis on the Immune Responses to Trivalent Influenza Vaccine (TIV) in Adults

Condition: Influenza; HIV; Tuberculosis

NCT ID: NCT01811823

Adjunct Immunotherapy With Immunoxel in Patients With TB and TB/HIV

Condition: Tuberculosis; HIV

NCT ID: NCT01061593

Nevirapine Drug Levels in HIV Positive Patients Also Receiving Rifampicin for Tuberculosis

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00617643

Efficacy Safety Study Comparing 2 Doses of NVP After Initiating Rifampin-containing TB Therapy

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00476853

Improving Latent Tuberculosis (TB) Diagnosis in Thai Children

Condition: Latent Tuberculosis; HIV Infections

NCT ID: NCT00947609

A Study to Determine the Best Dose of Antivirals in Patients With Both TB and HIV

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00523458

Characteristics and Prevalence of Tuberculosis and HIV in Masiphumelele Township, Cape Town, South Africa

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00346476

Nutrition, Diabetes and Pulmonary TB/HIV

Condition: Tuberculosis; HIV; Diabetes

NCT ID: NCT00311298

Paradoxical Tuberculosis Immune Reconstitution Inflammatory Syndrome (TB-IRIS) Treatment Trial

Condition: Immune Reconstitution Inflammatory Syndrome; Immune Reconstitution Syndrome; Tuberculosis; HIV-infection/Aids

NCT ID: NCT01442428

Preventive Therapy for Tuberculosis in HIV Infected Persons

Condition: Human Immunodeficiency Virus; Tuberculosis

NCT ID: NCT00351702

Early Antiretroviral Treatment and/or Early Isoniazid Prophylaxis Against Tuberculosis in HIV-infected Adults (ANRS 12136 TEMPRANO)

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00495651

Interaction Between High Dose Rifampicine and Efavirenz in Pulmonary Tuberculosis and HIV Co-infection

Condition: Tuberculosis; HIV

NCT ID: NCT01986543

Placebo-Controlled Trial of Safety and Efficacy of Thalidomide in Patients With Infections Due to Mycobacterium and/or HIV

Condition: Mycobacterium Avium-Intracellulare Infection; HIV Infections; Tuberculosis, Mycobacterium Infection

NCT ID: NCT00002104

Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in HIV-positive Adults.

Condition: Tuberculosis (TB)

NCT ID: NCT00707967

Simultaneous Versus Sequential Antiretroviral Therapy (ARV) Therapy and Mycobacterium Tuberculosis (MTB) Treatment

Condition: HIV; AIDS; Tuberculosis

NCT ID: NCT00737724

Vitamin A Therapy for Tuberculosis

Condition: Pulmonary Tuberculosis; HIV Infections

NCT ID: NCT00057434

Prevalence of HIV and Tuberculosis in Masiphumelele Township, Cape Town, South Africa

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00096681

TBTC Study 23C: Pharmacokinetics of Intermittent Rifabutin and Isoniazid With Daily Efavirenz

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00023413

Efficacy and Safety of Concomitant Use of Nevirapine and Rifampicin With HIV-TB

Condition: HIV/TB Co-infection

NCT ID: NCT01805258

A Registry of Tuberculosis Cases in the CPCRA

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00000785

Efavirenz-based Versus Nevirapine-based Antiretroviral Therapy Among HIV-infected Patients Receiving Rifampin

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00483054

Two-Stage Tuberculin (PPD) Skin Testing in Individuals With Human Immunodeficiency Virus (HIV) Infection

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00000955

Phase II Placebo Controlled Study of Thalidomide in Patients With Mycobacterial and HIV Infections

Condition: HIV Infections; Mycobacterium Infections; Tuberculosis

NCT ID: NCT00004276

Systematic Empirical vs. Test-guided Anti-TB Treatment Impact in Severely Immunosuppressed HIV-infected Adults Initiating ART With CD4 Cell Counts <100/mm3

Condition: HIV-1 Infection

NCT ID: NCT02057796

Safety and Efficacy of Two Once Daily Anti Retroviral Treatment Regimens Along With Anti-tuberculosis Treatment

Condition: Tuberculosis; Human Immunodeficiency Virus Infections

NCT ID: NCT00332306

Optimizing Clinical Outcomes in HIV-Infected Adults & Children

Condition: Tuberculosis Diagnosis; HIV

NCT ID: NCT02043080

Safety and Immunogenicity of AERAS-402 in HIV-infected, Bacillus Calmette-Guerin (BCG)-Vaccinated Adults

Condition: Tuberculosis; HIV Infections

NCT ID: NCT01017536

A Pilot Study of Methodology to Rapidly Evaluate Drugs for Bactericidal Activity, Tolerance, and Pharmacokinetics in the Treatment of Pulmonary Tuberculosis Using Isoniazid and Levofloxacin

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00000778

Early Versus Standard Start of Anti-HIV Therapy for Treatment-Naive Adults in Haiti

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00120510

Safety and Immunogenicity Study of a Candidate Tuberculosis Vaccine in Human Immunodeficiency Virus (HIV)-Positive Adults

Condition: Tuberculosis

NCT ID: NCT01262976

Collection of Tissue Specimens in Mali, West Africa, for HIV and Tuberculosis Research

Condition: Tuberculosis; HIV

NCT ID: NCT00341042

Comparison of Door-to-door Versus Community Gathering to Provide HIV Counseling and Testing Services in Rural Lesotho

Condition: HIV/AIDS; Tuberculosis; Diabetes Mellitus; Arterial Hypertension

NCT ID: NCT01459120

ENhance Initiation and Retention in Isoniazid Preventive Therapy (IPT) Care for HIV Study (ENRICH Study)

Condition: HIV; Tuberculosis

NCT ID: NCT01926379

Mentor Mothers: A Sustainable Family Intervention in South African Townships

Condition: Human Immunodeficiency Virus; Acquired Immune Deficiency Syndrome; Tuberculosis

NCT ID: NCT00972699

Drug Interaction Between Coartem® and Nevirapine, Efavirenz or Rifampicin in HIV Positive Ugandan Patients

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00620438

Interaction of Buprenorphine With HIV Medications and Tuberculosis Medications

Condition: Opioid Dependency; HIV Infections

NCT ID: NCT00877591

Identification of Cytokine Profiles and T Cell Subsets Among Immunosuppressed Patients at Risk of Developing Active Tuberculosis

Condition: Tuberculosis; HIV Infections; Rheumatoid Arthritis

NCT ID: NCT00285441

Start TB Patients on ART and Retain on Treatment (START Study)

Condition: Tuberculosis; HIV

NCT ID: NCT01872390

ART and Inflammatory and Coagulation Biomarkers

Condition: HIV (Human Immunodeficiency Virus); AIDS (Acquired Immune Deficiency Syndrome); Tuberculosis; Non-communicable Diseases (NCD)

NCT ID: NCT02027480

Safety And Efficacy Of Rifabutin In HIV Patients

Condition: Non-tuberculous Mycobacterial Diseases (Including MAC Disease); Tuberculosis; Inhibition of Disseminated Mycobacterium Avium Complex (MAC) Disease Associated With HIV Infections

NCT ID: NCT00810446

Rifampin and Nevirapine Interactions in Young Children

Condition: Tuberculosis; HIV

NCT ID: NCT01699633

Rifampin and Efavirenz Interactions in Older Children

Condition: HIV; Tuberculosis

NCT ID: NCT01704144

Safety, Tolerability, and Blood Levels of Ritonavir-Boosted Atazanavir and Rifampin When Taken Together in HIV Uninfected Adults

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00096850

Randomized Clinical Trial to Assess the Efficacy and Safety of Concomitant Use of Rifampicin and Efavirenz 600 X 800mg

Condition: Tuberculosis; HIV Infections

NCT ID: NCT00533390

EARNEST Rifabutin Pharmacokinetics (PK) Substudy

Condition: HIV; Tuberculosis

NCT ID: NCT01663168

Safety and Immunogenicity of MVA85A Prime and Bacille Calmette-Guerin Boost Vaccination

Condition: Tuberculosis; HIV

NCT ID: NCT01650389

Do Clinical Decision-support Reminders for Medical Providers Improve the Do Clinical Decision-support Reminders for Medical Providers Improve the Prevalence of IPT Initiation Among HIV Positive Adults in Western Kenya?

Condition: Tuberculosis

NCT ID: NCT01934309

An Evaluation of the Pharmacological Interaction of Lopinavir/r and Rifampin

Condition: HIV Infection; Tuberculosis

NCT ID: NCT00771498

REMEMBER: Reducing Early Mortality & Morbidity by Empiric Tuberculosis (TB) Treatment

Condition: HIV Infection

NCT ID: NCT01380080

Preventing Tuberculosis-associated Immune Reconstitution Inflammatory Syndrome in High-risk Patients: a Randomized Placebo-controlled Trial of Prednisone

Condition: HIV Associated Tuberculosis

NCT ID: NCT01924286

Safety and Efficacy of Oral Immunomodulator in Tuberculosis (TB) and TB/HIV Patients

Condition: Tuberculosis

NCT ID: NCT01222338

Enhanced TB Screening to Determine the Prevalence and Incidence of TB in Patients With HIV

Condition: Tuberculosis

NCT ID: NCT02043067

A Study to Evaluate the Safety and Efficacy of Azithromycin in Individual Patients With Serious Nontuberculous Mycobacterial Disease Who Are Failing or Intolerant of Other Available Therapy

Condition: Mycobacterium Avium-Intracellulare Infection; HIV Infections; Tuberculosis, Mycobacterium Infection

NCT ID: NCT00002085

TMC207-TiDP13-C110: Interaction Study With Lopinavir/Ritonavir in Healthy Volunteer

Condition: Tuberculosis; HIV

NCT ID: NCT00828529

Pharmacokinetic Study of Super-boosted Lopinavir/Ritonavir Given With Rifampin

Condition: AIDS; Tuberculosis

NCT ID: NCT01700790

Chepetsa TB - Reducing TB Among HIV-Infected Malawians

Condition: Tuberculosis

NCT ID: NCT01450085

Sustainable East Africa Research in Community Health

Condition: HIV; Tuberculosis; Hypertension; Diabetes; Maternal Child Health; Cost Effectiveness

NCT ID: NCT01864603

Arginine as an Adjuvant Treatment Against Tuberculosis

Condition: Tuberculosis; HIV

NCT ID: NCT00857402

A Bioavailability Study of Rifabutin and Lopinavir/Ritonavir in Healthy Adult Subjects

Condition: HIV; Tuberculosis

NCT ID: NCT00743470

A Phase I/IIa Safety & Immunogenicity of AERAS-456 in HIV-Negative Adults With & Without Latent Tuberculosis Infection (C-035-456)

Condition: Latent Tuberculosis Bacteriology and Histology Unknown; Latent Tuberculosis

NCT ID: NCT01865487

Tuberculosis Recurrence Upon Treatment With Highly Active Antiretroviral Therapy

Condition: Tuberculosis

NCT ID: NCT01539005

Cell Phone Messaging to Improve Communication of Critical Laboratory Results to Patients in Rural Uganda

Condition: HIV; Tuberculosis

NCT ID: NCT01579214

Isoniazid Prophylaxis With Concomitant Cotrimoxazole in HIV-infected Children

Condition: Tuberculosis

NCT ID: NCT00330304

A Phase I Randomized Placebo-Controlled, Double-Blind Study to Evaluate Safety and Immunogenicity of AERAS‑404 Administered as Different Amounts of Antigen and Adjuvant Combinations in HIV-Negative BCG-Vaccinated Adults Without Evidence of Tuberculosis Infection

Condition: Tuberculosis

NCT ID: NCT02066428

Faster Identification of TB and Evaluation of Drug Resistance in HIV-infected People

Condition: HIV Infections

NCT ID: NCT00959088

Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in Healthy HIV Negative Adolescents

Condition: Tuberculosis (TB)

NCT ID: NCT00950612

Dosing, Safety and Pharmacokinetic Profile of Rifabutin in Children Receiving Concomitant Treatment With Kaletra

Condition: Children With Confirmed HIV Infection; Receiving ART Regimen Containing 2 NRTIs + LPV/RTV at Standard Dose; Successfully Completed TB Treatment in the Past 2 to 6 Weeks of Enrollment

NCT ID: NCT01259219

A Phase I Study of a New Tuberculosis (TB) Vaccine, MVA85A, in Healthy Volunteers With HIV

Condition: Tuberculosis

NCT ID: NCT00731471

A Knowledge Translation Intervention for TB/HIV Treatment Adherence, in Zomba District, Malawi

Condition: Tuberculosis

NCT ID: NCT01356095

The Effect of Intermittent Rifampicin on Raltegravir

Condition: HIV; Tuberculosis

NCT ID: NCT01424826

Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever)

Condition: Visceral Leishmaniasis; Human African Trypanosomiasis; Enteric Fever; Melioidosis; Brucellosis; Leptospirosis; Relapsing Fever; Rickettsial Diseases; HIV; Tuberculosis; Malaria; Amoebic Liver Abscess

NCT ID: NCT01766830

Preliminary Evaluation of a Point-Of-Care Liver Function Test

Condition: HIV; Tuberculosis; Drug-Induced Liver Injury

NCT ID: NCT01705041

Optimal Dosing of 1st Line Antituberculosis and Antiretroviral Drugs in Children (a Pharmacokinetic Study)

Condition: Tuberculosis; HIV

NCT ID: NCT01637558

Safety, Tolerability, and Effect of TMC207 and Efavirenz in Healthy Volunteers

Condition: Tuberculosis; HIV

NCT ID: NCT00992069

A Trial of the Urine LAM Strip Test for TB Diagnosis Amongst Hospitalized HIV-infected Patients

Condition: Tuberculosis

NCT ID: NCT01770730

Early Bactericidal Activity of Linezolid, Gatifloxacin, Levofloxacin, Isoniazid (INH) and Moxifloxacin in HIV Negative Adults With Initial Episodes of Sputum Smear-Positive Pulmonary Tuberculosis

Condition: TB Multi-drug Resistant

NCT ID: NCT00396084

A Phase 1, Open Label, Placebo-Controlled Study to Evaluate the Effect of GSK1349572 on Iohexol and Para-Aminohippurate Clearance in Healthy Subjects

Condition: Infections, Human Immunodeficiency Virus and Tuberculosis

NCT ID: NCT01214993

Utility of Sputum Induction and Novel Technologies to Improve TB Diagnosis in a High HIV Prevalence Primary Care Setting

Condition: Tuberculosis

NCT ID: NCT01545661

Linkage and Retention: A Randomized Trial to Optimize HIV/TB Care in South Africa

Condition: HIV

NCT ID: NCT01188941

Acquired Immunodeficiency Syndrome(AIDS) and Tuberculosis(Tb) Co-infection Treatment Strategies Study of China.

Condition: AIDS

NCT ID: NCT01344148

Phase I Trial of DAR-901

Condition: Tuberculosis

NCT ID: NCT02063555

Interaction Study to Assess the Pharmacokinetic Interaction of Oral Administration of Rifapentine on ATRIPLA™ in HIV Patients

Condition: Tuberculosis

NCT ID: NCT01690403

Evaluation of the Pharmacokinetics of Antituberculosis Drugs and Tuberculosis Treatment Outcomes

Condition: AIDS With Tuberculosis

NCT ID: NCT01782950

Safety and Immunogenicity Study of AERAS-456 Vaccine for Tuberculosis

Condition: Latent Tuberculosis; Latent Tuberculosis Bacteriology and Histology Unknown

NCT ID: NCT01967134

Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in Pulmonary Tuberculosis Suspects

Condition: Tuberculosis

NCT ID: NCT01587469

Effects of Interferon-Gamma on Cavitary Pulmonary Tuberculosis in the Lungs

Condition: Tuberculosis; AIDS-Related Complex

NCT ID: NCT00201123

A Phase I Study to Evaluate Safety and Immunogenicity of AERAS 404 Administered in Adults

Condition: Tuberculosis

NCT ID: NCT02074956

Feasibility of a Lateral Flow Urine Lipoarabinomannan (LAM) Test for Diagnosis of Tuberculosis

Condition: Tuberculosis; Tuberculosis, Pulmonary; Tuberculosis, Miliary

NCT ID: NCT01525134

Feasibility of a Lateral Flow Urine LAM Test for Diagnosis of Tuberculosis in South Africa

Condition: Tuberculosis; Tuberculosis, Pulmonary; Tuberculosis, Miliary

NCT ID: NCT01693224

Study of Pre-clearance of Latent Tuberculosis Infection And BCG Revaccination

Condition: Mycobacterium Tuberculosis

NCT ID: NCT01119521

TB-IRIS NSAID Cox-2 Inhibitor Prevention Trial

Condition: Tuberculosis

NCT ID: NCT02060006

Tuberculosis Treatment Shortening Trial

Condition: Tuberculosis

NCT ID: NCT00130247

Moxifloxacin As Part of a Multi-Drug Regimen For Tuberculosis

Condition: Tuberculosis

NCT ID: NCT00082173

A Study to Evaluate Safety and Immunogenicity of AERAS-402

Condition: Tuberculosis

NCT ID: NCT01378312

Study of AERAS-402 in Healthy Infants

Condition: Tuberculosis

NCT ID: NCT01198366

TBTC Study 25PK: Intensive Pharmacokinetic Study of Three Doses of Rifapentine and 25-Desacetyl Rifapentine

Condition: Tuberculosis

NCT ID: NCT00023387

Dose-Escalation Study to Evaluate the Safety and Immunogenicity of MTBVAC Vaccine in Comparison With BCG Vaccine.

Condition: Tuberculosis; Healthy

NCT ID: NCT02013245

A Study of MVA85A in Healthy Infants

Condition: Tuberculosis

NCT ID: NCT00953927

A Phase I Study to Evaluate Safety and Immunogenicity of AERAS 404 (C-011-404)

Condition: Tuberculosis

NCT ID: NCT02109874

Study to Evaluate Safety and Immunogenicity of VPM1002 in Comparison With BCG in Newborn Infants in South Africa

Condition: Tuberculosis

NCT ID: NCT01479972

Immune Responses to Mycobacterium Tuberculosis

Condition: Mycobacterium Tuberculosis

NCT ID: NCT00340990

Immune Response to Mycobacterium Tuberculosis Infection

Condition: Latent Tuberculosis

NCT ID: NCT00257907

Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in Adults With TB Disease

Condition: Tuberculosis

NCT ID: NCT01424501

Study in Healthy Adults to Evaluate Gene Activation After Vaccination With GlaxoSmithKline (GSK) Biologicals' Candidate Tuberculosis (TB) Vaccine GSK 692342

Condition: Tuberculosis

NCT ID: NCT01669096

TMC207-TiDP13-C117: Interaction Study in Human Immunodeficiency Virus-type 1 (HIV-1) Infected Patients With Nevirapine (NVP)

Condition: HIV Infections

NCT ID: NCT00910806

TB Nutrition, Immunology and Epidemiology

Condition: Mycobacterium Tuberculosis

NCT ID: NCT00170404

Nutrition, Immunology and Epidemiology of Tuberculosis

Condition: Tuberculosis

NCT ID: NCT00197704

Evaluation of PTB Screening in ANC in Lusaka, Zambia

Condition: Pulmonary Tuberculosis

NCT ID: NCT02053129

Phase 1/II, Safety and Immunogenicity Study of AERAS-404 in BCG-Primed Infants

Condition: Tuberculosis

NCT ID: NCT01861730

Male Engagement in PMTCT Services

Condition: HIV

NCT ID: NCT01903889

Integrated Infectious Disease Capacity-Building Evaluation

Condition: Capacity Building; Support for Midlevel Health Professionals; Diagnostic Training

NCT ID: NCT01190540

Drug Interaction Study Between Rifabutin And Lersivirine (UK-453,061)

Condition: Healthy Volunteers

NCT ID: NCT00925535